Hypothyroidism News and Research

RSS
Hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormone to meet the body’s needs. Without enough thyroid hormone, many of the body’s functions slow down. About 5 percent of the U.S. population has hypothyroidism. Women are much more likely than men to develop hypothyroidism.
Five questions for successful weight loss

Five questions for successful weight loss

Study links thyroid disease with human exposure to PFOA

Study links thyroid disease with human exposure to PFOA

Website explores pros and cons of obesity

Website explores pros and cons of obesity

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Thyroid cancer on the rise

Thyroid cancer on the rise

AstraZeneca's CRESTOR receives favorable vote from FDA Advisory Committee

AstraZeneca's CRESTOR receives favorable vote from FDA Advisory Committee

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

9% of Québec adults report being diagnosed with a thyroid disease

9% of Québec adults report being diagnosed with a thyroid disease

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

Forest Laboratories places Armour Thyroid medication on back order

Forest Laboratories places Armour Thyroid medication on back order